Table 2. MIC of nanocomposites against nonresistant and resistant bacterial strains.

	Species	Activity & MIC (μg mL−1)	Fe2O3–Ag2O	Fe2O3–Ag2O@GO	Fe2O3–Ag2O@N-GO	Fe2O3–Ag2O@S-GO	Ciprofloxacin	DMSO
Non-resistant strains	S. aureus	Activity	Active	−ve	−ve	−ve	Active	−ve
		MIC	12.5				1.25
	B. subtilis	Activity	−ve	−ve	−ve	−ve	Active	−ve
		MIC					1.25
	K. pneumoniae	Activity	−ve	−ve	−ve	−ve	Active	−ve
		MIC					1.25
	E. coli	Activity	−ve	−ve	−ve	−ve	Active	−ve
		MIC					1.25
	P. aeruginosa	Activity	−ve	−ve	Active	Active	Active	−ve
		MIC			50	200	1.25
Resistant strain	Acinetobacter	Activity					Active
		MIC					1.25
	E. coli	Activity	Active	−ve	−ve	Active	Active	−ve
		MIC	25			25	1.25
	MRSA	Activity	−ve	−ve	−ve	Active	Active	−ve
		MIC				25	1.25